The RECK gene and biological malignancy-its significance in angiogenesis and inhibition of matrix metalloproteinases

Anticancer Research

Volumn 34, Issue 8, 2014, Pages 3867-3874

  Alexius Lindgren, Michelle ^a   Andersson, Erika ^a   Lindstedt, Ingrid ^a   Engström, Wilhelm ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

Author keywords

Metastasis; MMP; RECK; Review; VEGF

Indexed keywords

GLYCOPROTEIN; MATRIX METALLOPROTEINASE; RECK PROTEIN; UNCLASSIFIED DRUG; GELATINASE B; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MATRIX METALLOPROTEINASE INHIBITOR; RECK PROTEIN, HUMAN; VASCULOTROPIN;

ANGIOGENESIS; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE STRUCTURE; HUMAN; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN STRUCTURE; REVIEW; TUMOR SUPPRESSOR GENE; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; METASTASIS; MMP; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; RECK; VASCULARIZATION;

METASTASIS; MMP; RECK; REVIEW; VEGF;

ANIMALS; EXTRACELLULAR MATRIX; GPI-LINKED PROTEINS; HUMANS; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84908696558     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Lemmon MA and Schlessinger J: Cell signalling by receptor tyrosine kinases. Cell 141: 1117-1134, 2010.
2. Hanahan D and Weinberg RA: Hallmarks of cancer. Cell 144: 646-674, 2011.
3. Takahashi C, Zeqi Sheng Z, Thomas P: Horan TP, Hitoshi Kitayama, H Masatoshi Maki M, Kiyotaka Hitomi K and Yasuyuki Kitaura Y: Regulation of Matrix Metalloproteinase-9 and Inhibition of Tumor Invasion by the Membrane-Anchored Glycoprotein RECK. Proc Natl Acad Sci (USA) 95: 13221-13226, 1998.
4. Takeuchi T, Hisanaga M, Nagao M, Ikeda N, Fujii H, Koyama F, Mukogawa T, Matsumoto H, Kondo S and Takahashi C: The Membrane-Anchored Matrix Metalloproteinase (MMP) Regulator RECK in Combination with MMP-9 Serves as an Informative Prognostic Indicator for Colorectal Cancer. Clin Cancer Res 10: 5572-5579, 2004.
5. Takenaka K, Ishikawa S, Kawano Y, Yanagihara K, Miyahara R, Otake Y and Morioka Y: Expression of a Novel Matrix Metalloproteinase Regulator, RECK, and Its Clinical Significance in Resected Non-Small Cell Lung Cancer. Eur J Cancer 40: 1617-1623, 2004.
6. Zhang G, Cheng S, Zhang G, Ma W, Liu Y, Zhao R, Zhang Q and Pang D: Low Expression of RECK Indicates a Shorter Survival for Patients with Invasive Breast Cancer. Cancer Sci 103: 1084-1089, 2012.
7. Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S and Ito D: RECK Expression in Pancreatic Cancer Its Correlation with Lower Invasiveness and Better Prognosis.Clin Cancer Res 9: 1779-1784, 2003.
8. Egeblad M and Werb Z: New Functions for the Matrix Metalloproteinases in Cancer Progression. Nature Rev Cancer 2: 161-174. 2002.
9. Long NK, Kato K, Yamashita T, Makita H, Toida M, Hatakeyama D, Hara A, Mori H and Shibata T: Hypermethylation of the RECK Gene Predicts Poor Prognosis in Oral Squamous Cell Carcinomas. Oral Oncol 44: 1052-1058, 2008.
10. Tian M and Kamoun S: A Two Disulfide Bridge Kazal Domain from Phytophthora Exhibits Stable Inhibitory Activity against Serine Proteases of the Subtilisin Family. BMC Biochem 6: 15, 2005.
11. Clark JCM, David M. Thomas DM, Choong PFM and Dass CR: RECK-a Newly Discovered Inhibitor of Metastasis with Prognostic Significance in Multiple Forms of Cancer. Cancer Metast Rev 26: 675-683, 2007.
12. Wilson J: Cloning and Analysis of RECK during Early Xenopus Laevis Development. University of Western Ontario - Electronic Thesis and Dissertation Repository, November 30, 2012.
13. NCBI (2014-03-09). HomoloGene: 9622. http://www.ncbi.nlm.nih.gov/homologene/9622Last accessed 2014-03-12
14. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM and Nishimura S: The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis. Cell 107: 789-800, 2001.
15. Noda M, Oh J, Takahashi R, Kondo S, Kitayama H and Takahashi C: RECK, a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastat Rev 22: 167-175, 2003.
16. Peng X, Wu W, Zhu B, Sun Z, Ji L, Ruan Y, Zhou M, Zhou L, and Gu J: Activation of farnesoid receptor induces RECK expression in mouse liver. Biochem Biophys Res Comm 443: 211-216. 2014.
17. Zhang X, Healy C and Nothnick WB: Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion inducing cystein rich protein with Kazal motifs (RECK) within the mouse uterus. Endocrine 42: 97-106, 2012.
18. Namwat, N., Puetkasichonpasutha J, Loilome W, Yongvanit P, Techasen A, Puapairoj A, Sripa B, Tassaneeyakul T, Khuntikeo N and Wongkham S: Downregulation of Reversion-Inducing-Cysteine-Rich Protein with Kazal Motifs (RECK) Is Associated with Enhanced Expression of Matrix Metalloproteinases and Cholangiocarcinoma Metastases. J Gastroenterology 46: 664-675, 2010.
19. Chung TT, Yeh CB, Li YC, Su SC, Chien MH, Yang SF and Hsieh YH: Effect of RECK Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features PLoS ONE 7: e33517. 2012.
20. Chen Y and Tseng SH: The potential of RECK inducers as antitumour agents for glioma. Anticancer Res 32: 2991-2998, 2012.
21. Bos JL: Ras Oncogenes in Human Cancer: A Review. Cancer Res 49: 4682-4689, 1989.
22. Takagi S, Simizu S and Osada H: RECK Negatively Regulates Matrix Metalloproteinase-9 Transcription. Cancer Res 69: 1502-1508, 2009.
23. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K and Tanzawa K: Matrix Metalloproteinase-9 Triggers the Angiogenic Switch during Carcinogenesis. Nature Cell Biol 2: 737-744, 2000.
24. Vu TH: Matrix Metalloproteinases: Effectors of Development and Normal Physiology. Genes Developm 14: 2123-2133, 2000.
25. Chakraborti S, Malay Manda M, Sudip Das S, Amritlal Mandal A, and Tapati Chakraborti T; Regulation of Matrix Metalloproteinases: An Overview. Molecular and Cell Biochem 253: 269-285, 2003.
26. Fan X, Wang E, Wang X, Cong X and Chen X: MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase 9 via reversion inducing cysteine rich protein with Kazal motifs. Exp Mol Pathol 96: 242-249, 2014.
27. Stetler-Stevenson WG: Matrix Metalloproteinases in Angiogenesis: A Moving Target for Therapeutic Intervention. J Clin Investig 103: 1237-1241, 1999.
28. Tammela TB, Enholm B, Alitalo K and Paavonen K: The Biology of Vascular Endothelial Growth Factors. Cardiovascular Res 65: 550-563, 2004.
29. Aricò A, Giantin M, Gelain ME, Riondato F, Comazzi S, Rütgen BC, Essler SE, Mauro Dacasto M, Castagnaro M and Aresu L; The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study. BMC Vet Res 9: 94, 2013.
30. Giantin M, Aresu L, Benali S, Aricò A, Morello EM, Martano M and Vascellari M: Expression of Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases and Vascular Endothelial Growth Factor in Canine Mast Cell Tumours. J Comp Path 147: 419-429, 2012.
31. Hlatky L, Hahnfeldt P and Folkman J: Clinical Application of Antiangiogenic Therapy: Microvessel Density, What It Does and Doesn't Tell Us. J Natl Cancer Inst 94: 883-893, 2002.
32. Takagi S, Kitamura T, Hosaka Y, Ohsaki T, Bosnakovski D, Kadosawa T, Okumura M and Fujinaga T: Molecular Cloning of Canine Membrane-Anchored Inhibitor of Matrix Metalloproteinase, RECK. J Vet Med Sci 67: 385-391, 2005.
33. Sakurai F, Nanjo Y, Okamoto S, Tachibana M and Mizuguchi H: Up-regulation of RECK gene expression by small double stranded RNA targeting the promoter region. Cancer Gene Ther 21: 164-170, 2014.